
    
      The study will include the first 188 subjects who are randomized. The purpose of study is to
      collect efficacy results to evaluate treatment effect on the primary endpoint. The second
      endpoints is to evaluate drug safety on the incidence of the primary endpoint through the
      treatment period.
    
  